In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.